• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astrotech Corporation (DE) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    12/17/25 4:05:25 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ASTC alert in real time by email
    astc20251216_8k.htm
    false 0001001907 0001001907 2025-12-12 2025-12-12
     


     
    UNITED STATES
     
    SECURITIES AND EXCHANGE COMMISSION
     
    WASHINGTON, DC 20549
     

     
    FORM 8-K
     

     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
     
    Date of report (Date of earliest event reported): December 12, 2025
     
     

     
    logo.jpg
     
     
    Astrotech Corporation
     
    (Exact Name of Registrant as Specified in Charter)
     
     
    Delaware
     
    001-34426
     
    91-1273737
    (State or Other Jurisdiction
    of Incorporation)
     
    (Commission
    File Number)
     
    (I.R.S. Employer
    Identification No.)
       
    1817 W. Braker Lane, Suite 400, Austin, Texas
     
    78758
    (Address of Principal Executive Offices)
     
    (Zip Code)
     
    (512) 485-9530
     
    Registrant’s Telephone Number, Including Area Code
     
    (Former Name or Former Address, if Changed Since Last Report)
     
     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐
    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
     
    ☐
    Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
     
    ☐
    Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
     
    Trading
    Symbol(s)
     
    Name of each exchange on which registered
    Common Stock, $0.001 par value per share
     
    ASTC
     
    NASDAQ Stock Market, LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 1.01. Entry into a Material Definitive Agreement.
     
    As previously disclosed, on December 21, 2022, Astrotech Corporation, a Delaware corporation (the “Company”), entered into a Rights Agreement (the “Rights Agreement”) with Equiniti Trust Company (f/k/a American Stock Transfer & Trust Company, LLC), a New York limited liability company, as rights agent (the “Rights Agent”), as amended by that certain Amendment No. 1, entered into by and between the Company and the Rights Agent on December 18, 2023, and further amended by that certain Amendment No. 2, entered into by and between the Company and the Rights Agent on December 12, 2024.
     
    On December 12, 2025, the Company entered into Amendment No. 3 to the Rights Agreement with the Rights Agent (the “Amendment”), which amends the Rights Agreement. The Amendment extends the Final Expiration Date (as defined in the Rights Agreement) to 5:00 P.M., New York City time, on December 20, 2026, unless the Final Expiration Date is further extended by the Company or the rights subject to the Rights Agreement (the “Rights”) are earlier redeemed or exchanged by the Company in accordance with the terms of the Rights Agreement. All other terms and conditions of the Rights Agreement remain unchanged.
     
    The Rights are in all respects subject to and governed by the provisions of the Rights Agreement, as amended by the Amendment. The descriptions of the Rights Agreement, the previous amendments and the Amendment are qualified in their entirety by reference to the full text of the Rights Agreement, the previous amendments and the Amendment, copies of which are attached hereto as Exhibit 4.1, Exhibit 4.2, Exhibit 4.3 and Exhibit 4.4 respectively, and each of which is incorporated herein by reference.
     
    Item 3.03. Material Modifications of Rights of Security Holders.
     
    The information set forth under the caption “Item 1.01. Entry into a Material Definitive Agreement” is incorporated herein by reference.
     
    Item 5.07 Submission of Matters to a Vote of Security Holders
     
    On December 12, 2025, the Company held its annual meeting of stockholders (the “Annual Meeting”), pursuant to notice duly given, at 1817 West Braker Lane, Suite 400, Austin Texas 78758. Of the 1,769,269 shares of Company’s common stock, $0.001 par value per share (“Common Stock”), entitled to vote at the Annual Meeting, 969,211 shares were present in person or by proxy. The matters voted upon at the Annual Meeting and the results of such voting are set forth below:
     
    Proposal 1 - Election of Directors
     
    By the votes reflected below, our stockholders elected the following individuals to serve as directors to serve for the respective terms prescribed by the Company’s bylaws:
     
    Nominee
     
    Votes For
     
    Votes Withheld
     
    Broker Non-Votes
    Thomas B. Pickens III
     
    290,435
     
    206,277
     
    N/A
    Tom Wilkinson
     
    267,997
     
    228,715
     
    N/A
    Bob McFarland
     
    279,950
     
    216,762
     
    N/A
    Eric Stober
     
    293,634
     
    203,078
     
    N/A
    Charles Winn
     
    292,049
     
    204,663
     
    N/A
    John Halinski
     
    294,672
     
    202,040
     
    N/A
     
    Proposal 2 - Ratification of Selection of Independent Registered Public Accounting Firm
     
    By the votes reflected below, our stockholders ratified the appointment of RBSM LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026:
     
    Votes For
     
    Votes Against
     
    Votes Withheld
     
    Broker Non-Votes
    935,627
     
    20,631
     
    12,952
     
    451,868
     
     

     
     
    Item 9.01 Financial Statements and Exhibits.
     
    Exhibit
    No.
     
    Description
         
    4.1
     
    Rights Agreement between the Company and Equiniti Trust Company (f/k/a American Stock Transfer & Trust Company, LLC), as Rights Agent, dated as of December 21, 2022 (incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-K filed with the Securities and Exchange Commission on December 21, 2022).
    4.2
     
    Amendment No. 1 to Rights Agreement by and between the Company and American Stock Transfer & Trust Company, LLC, as Rights Agent, dated as of December 18, 2023 (incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed with the Securities and Exchange Commission on December 18, 2023).
    4.3
     
    Amendment No. 2 to Rights Agreement by and between the Company and Equiniti Trust Company (f/k/a American Stock Transfer & Trust Company, LLC), as Rights Agent, dated as of December 12, 2024 (incorporated by reference to Exhibit 4.3 of the Registrant’s Form 8-K filed with the Securities and Exchange Commission on December 13, 2024).
    4.4*
     
    Amendment No. 3 to Rights Agreement dated as of December 12, 2025 to the Rights Agreement between the Company and Equiniti Trust Company, as Rights Agent, dated as of December 21, 2022.
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document).
     
    * Filed herewith
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    Astrotech Corporation
         
    December 17, 2025
    By:
    /s/ Thomas B. Pickens III
       
    Thomas B. Pickens III
       
    Chief Executive Officer, Chief Technology Officer and Chairman of the Board
     
     
    Get the next $ASTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Becker James Frank bought $19,675 worth of shares (2,034 units at $9.67), increasing direct ownership by 14% to 16,121 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/30/24 9:16:58 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Hinojosa Jaime bought $8,541 worth of shares (900 units at $9.49), increasing direct ownership by 13% to 7,881 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/28/24 9:46:54 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Wilkinson Thomas Wiley bought $10,536 worth of shares (1,109 units at $9.50), increasing direct ownership by 6% to 20,862 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/21/24 12:54:36 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    SEC Filings

    View All

    Astrotech Corporation (DE) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    12/17/25 4:05:25 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form DEFA14A filed by Astrotech Corporation (DE)

    DEFA14A - ASTROTECH Corp (0001001907) (Filer)

    12/2/25 4:17:04 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Astrotech Corporation (DE)

    10-Q - ASTROTECH Corp (0001001907) (Filer)

    11/13/25 4:25:56 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Bartley Scott claimed no ownership of stock in the company (SEC Form 3)

    3 - ASTROTECH Corp (0001001907) (Issuer)

    11/13/25 4:41:50 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Large owner Leonard Braden Michael sold $1,625,071 worth of shares (229,576 units at $7.08), closing all direct ownership in the company (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    10/7/25 8:51:19 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Badugu Nihanth

    3 - ASTROTECH Corp (0001001907) (Issuer)

    8/28/25 5:16:34 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    1st Detect's Aviation Security Technology Ready to Support the U.S. Aviation Security Modernization Initiative

    AUSTIN, Texas, Dec. 12, 2025 (GLOBE NEWSWIRE) --  Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") today announced its support of the Department of Homeland Security's ("DHS") recent initiative to modernize aviation security screening and technology nationwide. On November 22, 2025, DHS Secretary Kristi Noem announced a $1 billion nationwide plan to upgrade Transportation Security Administration ("TSA") equipment and security screening. 1st Detect Corporation stands ready to deploy its TRACER 1000™ detection systems to support such initiatives. The Company's TRACER 1000 detection systems, approved by both the TSA for air cargo screening and the European Civil Aviation Co

    12/12/25 4:25:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Announces Review of Strategic Alternatives to Maximize Shareholder Value

    AUSTIN, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will include a range of potential actions, including raising equity capital, reverse mergers, combination transactions, and the sale of all or part of the Company's business, and other possible strategic or financial transactions. "We remain confident in our differentiated mass spectrometry and gas chromatography technologies, and in the specific end market applications we have developed to create value in large end m

    11/19/25 9:15:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Reports First Quarter of Fiscal Year 2026 Financial Results

    AUSTIN, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the first quarter of fiscal year 2026, which ended September 30, 2025. Financial Highlights & Recent Developments    Revenue increased to $297 thousand or 35% in the first quarter of fiscal year 2026 as compared to the fourth quarter of fiscal year 2025 as Astrotech's subsidiary, 1st Detect, had more grant revenue and sold more consumables compared to prior quarter.As of September 30, 2025, the Company has deployed the TRACER 1000 in approximately 34 locations in 16 countries across the United States, Europe and Asia.On August 18, 2025, the

    11/13/25 4:15:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Leadership Updates

    Live Leadership Updates

    View All

    Astrotech Corporation Appoints Scott Bartley as Interim Chief Financial Officer

    AUSTIN, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or ("Astrotech"), today announced that it has appointed Scott Bartley as Interim Chief Financial Officer ("CFO") of the Company, effective as of October 20, 2025. "We are pleased to announce Scott Bartley as Chief Financial Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "He brings over two decades of expertise as a Controller and CFO, across multiple industries, providing important qualification and vantage points for our business across multiple end markets."​Mr. Bartley, age 56, has served as a financial consultant since 2011, inclu

    10/31/25 4:15:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer

    AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech"), today announced that it has appointed Nihanth Badugu as Chief Operating Officer ("COO") of the Company. Mr. Badugu's appointment is effective as of August 13, 2025. "The Board is thrilled to promote Mr. Badugu to Chief Operating Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "Nihanth has been an invaluable asset to Astrotech since joining us in 2023. His dedication to operational excellence and program management has significantly advanced our objectives. We are confident in his ability to lead our operations as COO a

    8/18/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer

    AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or ("Astrotech"), today announced that it has appointed Jennifer Cañas as Chief Financial Officer ("CFO") of the Company. Ms. Cañas' appointment is effective as of May 22, 2025. "The Board is delighted to promote Ms. Cañas to Chief Financial Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "I have worked with Ms. Cañas since 2022 and have found her to be hard working, competent and knowledgeable. Management and the Board of Directors are excited to promote Jennifer to this position as she demonstrated strong leadership and delivered solid

    5/28/25 5:25:00 PM ET
    $ASTC
    $HTO
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Water Supply
    Utilities

    $ASTC
    Financials

    Live finance-specific insights

    View All

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA's thoro

    4/8/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

    AUSTIN, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it will be showcasing its TRACER 1000 Narcotics Trace Detector ("NTD") and Explosives Trace Detector ("ETD") at the International Security Conference and Exposition, also known as ISC West, in Las Vegas, Nevada, from April 9-12, 2024, in booth number 2067. The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ ("AMS Technology"). Our mass spectrometer is capable of rapid detection of trace levels of narcotic or explosive compounds in

    4/2/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Introduces the "Gold Standard" of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

     AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it is currently accepting orders for the Tracer 1000 Narcotics Trace Detector (NTD). The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds. Currently, the Company's Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world. The NTD provides a ruggedized platform that can be applied across various markets including airports, border security, checkpoint, cargo,

    3/25/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Astrotech Corporation (DE)

    SC 13D - ASTROTECH Corp (0001001907) (Subject)

    6/26/23 4:00:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 5:29:16 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 4:02:50 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials